- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07827820
Ketogenic Feeding for Muscle Preservation After Trauma (KETO TRAUMA)
Ketogenic Feeding to Preserve Muscle Mass in Middle-aged and Older Trauma Injury Patients
The purpose of this study is to determine whether a ketogenic diet, provided as tube feeding, compared with a standard hospital tube feeding, is safe and feasible and helps preserve muscle mass and improve metabolic health in adults aged 55 years and older hospitalized with traumatic injury.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
- University of Alabama at Birmingham
-
Contact:
- Robert Mankowski, PhD
- Phone Number: 2059963006
- Email: rmankowski@uabmc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 55 years and older
- Traumatic injury
- Expected to survive and at least 10-day stay in the hospital
- Expected to be enterally fed for at least 10 days
- Willingness to be randomized to either treatment group
- Willingness to participate in all study procedures
Exclusion Criteria:
- Failure to provide informed consent
- Moribund
- Vegeterian/vegan
- Diagnosed dementia
- Hip fracture, hip or knee replacement, or spinal surgery within past 4 months
- Simultaneous participation in another intervention trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Ketogenic feeding
The ketogenic feeding will have a macronutrient composition of approximately 10% energy from carbohydrates, 25% energy from protein, and 65% energy from fat. |
The ketogenic feeding will have a macronutrient composition of approximately 10% energy from carbohydrates, 25% energy from protein, and 65% energy from fat. |
|
Placebo Comparator: Standard feeding
The participant will receive standard hospital care feeding. |
The participants will receive standard hospital care feeding. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Adverse Events
Time Frame: At baseline and 10-day of feeding
|
Number of adverse events collected using a standardized adverse event reporting form (Unit: Count of events). |
At baseline and 10-day of feeding
|
|
Adherence to the Intervention
Time Frame: From baseline to 10 days follow-up.
|
Percentage of prescribed intervention sessions completed, assessed through adherence logs and system usage records (Unit: %) |
From baseline to 10 days follow-up.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300016623
- UAB Team Science Grant Program (Other Grant/Funding Number: The University of Alabama at Birmingham)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.